Hypoglycemic Agents

"Hypoglycemic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Substances which lower blood glucose levels.

Descriptor ID	D007004
MeSH Number(s)	D27.505.696.422
Concept/Terms	Hypoglycemic Agents Hypoglycemic Agents Agents, Hypoglycemic Antihyperglycemics Antihyperglycemic Agents Agents, Antihyperglycemic Hypoglycemic Drugs Drugs, Hypoglycemic Hypoglycemics Hypoglycemic Effect Hypoglycemic Effect Effect, Hypoglycemic Hypoglycemic Effects Effects, Hypoglycemic Antidiabetics Antidiabetics Antidiabetic Drugs Drugs, Antidiabetic Antidiabetic Agents Agents, Antidiabetic

Below are MeSH descriptors whose meaning is more general than "Hypoglycemic Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Physiological Effects of Drugs [D27.505.696]
Hypoglycemic Agents [D27.505.696.422]

Below are MeSH descriptors whose meaning is more specific than "Hypoglycemic Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hypoglycemic Agents" by people in this website by year, and whether "Hypoglycemic Agents" was a major or minor topic of these publications.

Bar chart showing 180 publications over 24 distinct years, with a maximum of 14 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2001	1	0	1
2002	5	3	8
2003	3	4	7
2004	2	4	6
2005	9	2	11
2006	4	1	5
2007	1	3	4
2008	3	7	10
2009	6	1	7
2010	3	4	7
2011	9	1	10
2012	4	4	8
2013	9	4	13
2014	7	1	8
2015	8	6	14
2016	8	1	9
2017	8	3	11
2018	2	3	5
2019	8	2	10
2020	4	3	7
2021	1	4	5
2022	0	3	3
2023	0	6	6
2024	2	3	5

Below are the most recent publications written about "Hypoglycemic Agents" by people in Profiles.

Bisht P, Bhattacharya A, Pal A, Singh R, Verma SK. Design and synthesis of novel 3,7-dihydro-1H-purine-2,6-diones as DPP-4 inhibitors: An in silico, in vitro and in vivo approach. Eur J Med Chem. 2025 Feb 05; 283:117160.

View in: PubMed
Patel R, Wadid M, Makwana B, Kumar A, Khadke S, Bhatti A, Banker A, Husami Z, Labib S, Venesy D, Fonarow G, Kosiborod M, Al-Kindi S, Bhatt DL, Dani S, Nohria A, Butler J, Ganatra S. GLP-1 Receptor Agonists Among Patients?With Overweight or Obesity,?Diabetes,?and HFpEF on SGLT2?Inhibitors. JACC Heart Fail. 2024 Nov; 12(11):1814-1826.

View in: PubMed
Bhanushali KB, Asnani HK, Nair A, Ganatra S, Dani SS. Pharmacovigilance study for SGLT 2 inhibitors- Safety review of real-world data & randomized clinical trials. Curr Probl Cardiol. 2024 Sep; 49(9):102664.

View in: PubMed
Mo Z, Zhan M, Yang X, Xie P, Xiao J, Cao Y, Xiao H, Song M. Fermented dietary fiber from soy sauce residue exerts antidiabetic effects through regulating the PI3K/AKT signaling pathway and gut microbiota-SCFAs-GPRs axis in type 2 diabetic mellitus mice. Int J Biol Macromol. 2024 Jun; 270(Pt 2):132251.

View in: PubMed
Chen F, Mangano KM, Garelnabi M, Cardaleen K, Tucker KL. Associations among diabetes medication use, serum magnesium, and insulin resistance in a cohort of older Puerto Rican adults. Am J Clin Nutr. 2024 06; 119(6):1523-1532.

View in: PubMed
O'Connor MJ, Ding X, Hernandez C, Hubacz L, Church RJ, O'Connor L. A Pilot Trial of Continuous Glucose Monitoring Upon Emergency Department Discharge Among People With Diabetes Mellitus. Endocr Pract. 2024 Feb; 30(2):122-127.

View in: PubMed
Yusim D, Tiru B, Abdullin M, Landry DL, Hodgins S, Braden GL. Treatment of severe metformin-associated lactic acidosis with renal replacement therapy and tris-hydroxymethyl aminomethane: a case report. J Med Case Rep. 2023 Oct 20; 17(1):462.

View in: PubMed
Wilkie GL, Delpapa E, Leftwich HK. Intrapartum continuous subcutaneous insulin infusion vs intravenous insulin infusion among pregnant individuals with type 1 diabetes mellitus: a randomized controlled trial. Am J Obstet Gynecol. 2023 12; 229(6):680.e1-680.e8.

View in: PubMed
Lopez-Candales A, Monte S, Sawalha K, Norgard NB. Time to revisit the true role of metformin in type 2 diabetes mellitus. Postgrad Med. 2023 08; 135(6):539-542.

View in: PubMed
Dinesh D, Lee JS, Scott TM, Tucker KL, Palacios N. Association between Acid-Lowering Agents, Metformin, and Vitamin B12 among Boston-Area Puerto Ricans. J Nutr. 2023 08; 153(8):2380-2388.

View in: PubMed

People

Explore

Similar Concepts

Top Journals